Header graphic for print

Food Safety News

Breaking news for everyone's consumption

E. coli vaccine

K-State researcher gets $2M grant to develop E. coli vaccines

Weiping Zhang, professor of microbiology and a researcher with Kansas State University’s College of Veterinary Medicine, has received a five-year, $2.1-million grant from the National Institutes of Health to further his work on developing vaccines for E. coli-associated diarrhea in both humans and animals. The grant is Zhang’s third he’s received in three years in… Continue Reading

Study: E. Coli Vaccines Are Effective But Economic Incentive Needed

Despite the proven effectiveness of vaccines designed to decrease the presence of E. coli bacteria in cattle by as much as 98 percent, beef producers are not likely to widely adopt the practice of vaccinating their herds until there is a clear economic incentive, according to a new study by economics researchers at Kansas State University. Often… Continue Reading

Study: E. Coli Infections Cost Canada $400 Million Annually

A study funded by a Canadian biopharmaceutical company estimates that the combined health-care and productivity costs to Canada from verotoxigenic E. coli-related (VTEC) infections total about $404 million per year. The peer-reviewed study, to be published in the Journal of Food Protection, indicates that 93 percent of VTEC infections are caused by the E. coli… Continue Reading

E. Coli Vaccine Pilot Program Proposed by Food Safety Cooperative

Food safety cooperative VeriPrime has proposed a pilot program that would test the preventive effectiveness of E. coli vaccines in cattle and expand their use. “We’re looking to reduce E. coli in beef and E. coli in the environment as well,” said veterinarian Scott Crain, VeriPrime founder and CEO. The five-year on-farm intervention would begin by… Continue Reading

Study: E. Coli Cattle Vaccination Could Prevent 83 Percent of Human Cases

A recent study published in the Proceedings of the National Academy of Sciences suggests that using E. coli vaccines on cattle could prevent up to 83 percent of human infections. By combining veterinary, human and molecular data, the authors created a model of the pathogen’s transmission from cattle to humans and used it to estimate… Continue Reading

A Made-in-Canada Solution to E. coli O157 Outbreaks


The recent largest beef recall in Canadian history and its resulting economic and health consequences illustrates the complexities and difficulties associated with Canadian beef safety. However, there is currently a simple, unused, practical and economically viable solution to avoiding such beef recalls as well as preventing E. coli O157 outbreaks — we should vaccinate cattle… Continue Reading

UK Approves E. coli O157:H7 Vaccine for Cattle

A Canadian vaccine designed to reduce E. coli O157:H7 shedding in cattle has become the first drug of its kind to be approved for use in the United Kingdom. The medication – manufactured by Bioniche Life Sciences, Inc. – was granted a Special Treatment Certificate (STC) by the UK’s Veterinary Medical Directorate, a branch of… Continue Reading

Cargill Likes O157:H7 Vaccine Trial Performance

Vaccines administered by Cargill Meat Solutions to 85,000 head of cattle in the Fort Morgan, CO area this past May through August are showing potential promise for reducing E. coli O157:H7 in beef. Cargill’s large-scale tests of E coli O157:H7 vaccines, announced last January, were successful enough that the meat giant rolled out some of… Continue Reading